Schonfeld Strategic Advisors LLC Astrazeneca PLC Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 37,100 shares of AZN stock, worth $2.87 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
37,100
Previous 443,949
91.64%
Holding current value
$2.87 Million
Previous $30.1 Million
90.38%
% of portfolio
0.02%
Previous 0.21%
Shares
21 transactions
Others Institutions Holding AZN
# of Institutions
1,337Shares Held
491MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.02 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.29 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.14 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.84 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.36 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...